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Open access under the EDihydroorotate dehydrogenases (DHODHs) are enzymes that catalyze the fourth step of the de novo syn-
thesis of pyrimidine nucleotides. In this reaction, DHODH converts dihydroorotate to orotate, using a ﬂa-
vine mononucleotide as a cofactor. Since the synthesis of nucleotides has different pathways in mammals
as compared to parasites, DHODH has gained much attention as a promising target for drug design. Esch-
erichia coli DHODH (EcDHODH) is a family 2 DHODH that interacts with cell membranes in order to pro-
mote catalysis. The membrane association is supposedly made via an extension found in the enzyme’s N-
terminal. In the present work, we used site directed spin labeling (SDSL) to speciﬁcally place a magnetic
probe at positions 2, 5, 19, and 21 within the N-terminal and thus monitor, by using Electron Spin Res-
onance (ESR), dynamics and structural changes in this region in the presence of a membrane model sys-
tem. Overall, our ESR spectra show that the N-terminal indeed binds to membranes and that it
experiences a somewhat high ﬂexibility that could be related to the role of this region as a molecular
lid controlling the entrance of the enzyme’s active site and thus allowing the enzyme to give access to
quinones that are dispersed in the membrane and that are necessary for the catalysis.
 2011 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
Dihydroorotate dehydrogenase (DHODH) is a ﬂavin-containing
enzyme that catalyzes the oxidation of L-dihydroorotate to orotate,
the fourth and only redox step in the de novo pyrimidine biosyn-
thesis pathway [1]. DHODH has been considered an important tar-
get for the design of antiproliferative and antiparasitic agents once
inhibition of DHODH leads to reduced levels of pyrimidine precur-
sors which are important for performing a broad range of cellular
functions such as cell growth, metabolism and differentiation [2–
4].
For DHODHs, the conversion of dihydroorotate to orotate has
been described to follow a sequential ping–pong mechanism
[5,6]. In the ﬁrst half-reaction comprising the reduction of dihydro-
orotate to orotate, electrons are transferred to the ﬂavine mononu-
cleotide moiety (FMN) which becomes oxidized to dihydroﬂavin
mononucleotide (FMNH2). After dissociation of orotate from the
enzyme, FMNH2 is regenerated by an appropriate electron
receptor.ica, Faculdade de Filosoﬁa,
900, Ribeirão Preto, SP, Brazil.
lho).
lsevier OA license.Based on amino acid sequence similarity, cell location and sub-
strate speciﬁcity, DHODHs from different organisms can be divided
in two families [1]. Family 1 members are cytosolic enzymes of
Gram-positive bacteria, Archea and some unicellular eukaryotes,
and is further divided into 1A and 1B depending upon their elec-
tron receptor and oligomeric state. Family 1A members are dimeric
enzymes and utilize fumarate as the electron receptor. Family 1B
enzymes form heterotetramers and utilize NAD+ via a distinct pro-
tein subunit that contains a 2Fe–2S cluster and a FAD cofactor [7].
Enzymes of family 2 exist as monomers and are membrane-bound
enzymes that utilize quinones as the physiological oxidant during
the second half-reaction. The DHODH in family 2 include the en-
zyme from Escherichia coli (EcDHODH), which is attached to the
cell membrane [8,9], as well as the enzymes from higher eukary-
otes, e.g., Homo sapiens, Plasmodium falcipurum, which are localized
in the inner membrane of mitochondria [10].
DHODHs fold into an a/b barrel with the central barrel of eight
parallel b strands surrounded by eight a helices. Two antiparallel b
strands are found at the bottom of the barrel, whereas additional
secondary structural elements and loops form a protuberant sub-
domain present at the top of the barrel [11,12]. The prosthetic
FMN group is located between the top of the barrel and the subdo-
main formed by these insertions. In addition to this main barrel,
DHODHs of family 2 contain an extra N-terminal domain situated
488 S.G. Couto et al. / Biochemical and Biophysical Research Communications 414 (2011) 487–492next to the barrel and which folds into two a-helices and one 310
helix [13–15].
Kinetic and structural studies revealed distinct mechanisms for
substrate binding when comparing family 1 and 2 DHODHs [16].
Although for all DHODHs the pyrimidine-binding site is found on
the si face of the ﬂavin, where the ﬁrst reductive half-reaction
takes place, the oxidative half-reactions for each family are differ-
ent. In family 1, the dihydroorotate/orotate binding site is also de-
scribed to be occupied by the oxidant agent [6]. For family 2
members, the N-terminal extension has been proposed to harbor
the quinone-binding site, leading the electron acceptor to the
FMN cofactor for the redox reaction [13]. This hydrophobic tun-
nel-like pocket formed by the N-terminal domain has also been
found to be the target for drug development [13–17].
To date there is limited information on the mechanism of mem-
brane binding and quinone diffusion in family 2 DHODHs. In our
previous work, using E. coli DHODH (EcDHODH) as the model sys-
tem, we have showed that the interaction between family 2 DHO-
DH and model membranes causes a defect-like structure in the
membrane hydrophobic region, which is probably the mechanism
used by the protein to capture quinones used as electron acceptors
during catalysis [18]. In the present work, we have moved forward
and investigated the structural changes in the DHODH N-terminal
domain in the presence of a membrane model system. To achieve
this goal we produced mutants of EcDHODH bearing spin probes
in the N-terminal extension. This was done by means of site direc-
ted mutagenesis in which a native residue was changed to a cys-
teine that was in turn speciﬁcally labeled with a nitroxide-like
probe. This is the basic idea governing the so-called site directed
spin labeling technique that, along with ESR experiments, allow
one to characterize dynamics and conformational changes occur-
ring during protein function [19–22]. Our results give clear exper-
imental evidences that the N-terminal extension is indeed
responsible for the association with the membrane, a paramount
step for the enzyme catalysis, and also shed light on the conforma-
tional dynamics experienced by that region in presence of the
membrane model.2. Materials and methods
2.1. Materials
1-Dipalmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (DOPC)
was obtained from Avanti Polar Lipids, Inc. (Birmingham, AL).
The sulfhydryl reactive spin-label (1-oxyl-2,2,5,5-tetramethyl-3-
pyrroline-3-methyl) methanethiosulfonate (MTSL) was purchased
from Toronto Research Chemicals, Inc. (North Fork, ON).2.2. Construction, expression, puriﬁcation and spin labeling of
EcDHODH mutants
The template EcDHODH gene used for mutagenesis was that
coding for the cysteine-free ‘‘pseudo-wild-type’’ protein containing
the substitutions C48A, C70A, C158A, and C260A (Mutagenx, NJ).
Single cysteine residues were introduced at positions Y2, F5, H19,
and F21 of EcDHODH using three-step PCR method. Mutations
were conﬁrmed by nucleotide sequencing [23].
EcDHODHmutants were expressed in E. coli strain SO6740 [24].
Protein expression was induced by addition of 750 lM isopropyl b-
D-thiogalactopyranoside (IPTG). The cells were grown overnight in
Luria-Broth medium at 37 C with vigorous shaking. The cells were
collected by centrifugation at 4000g for 30 min. EcDHODHmutants
were puriﬁed as described for the wild-type enzyme [18]. Each
EcDHODHmutant was tested to determine whether they were sta-
ble and active. The activity test of the EcDHODH mutants was per-formed as described by Bjornberg et al. [24]. The mutants were
then spin labeled with a 10-fold molar excess of the MTSL spin-
label after anion exchange chromatography. Spin labeling pro-
ceeded overnight at 4 C under gentle shaking. The unbound label
molecules were removed by using dialysis through centrifugal ﬁl-
ter devices.
2.3. ESR spectroscopy
Aliquots of a chloroform stock solution of the phospholipid
DOPC were dried inside a glass tube by using a nitrogen ﬂow.
The dried ﬁlm was resuspended with the solution containing
spin-labeled protein mutants. The ﬁnal solution for each mutant
(50–200 lM) was drawn into a quartz ﬂat cell for ESR experiments.
ESR spectra were acquired using a Varian E109 X-band (9.4 GHz)
spectrometer. All experiments were carried out at room tempera-
ture and several scans were performed to achieve a good signal-
to-noise ratio. Experimental parameters were set to avoid satura-
tion and distortions of the ﬁnal spectrum and included: magnetic
ﬁeld range of 100 G, microwave power of 20 mW, modulation
amplitude of 1.0 G.
2.4. NLSL simulations
Non-linear least-squares simulations were performed using the
NLLS software, which is based on Freed’s developments of the Sto-
chastic Liouville Equation (SLE) [25,26] and implemented in the
LabView graphical interface made available by Dr. Christian Alten-
bach (UCLA) at https://sites.google.com/site/altenbach/labview-
programs/epr-programs/multicomponent. The routine solves the
SLE for a nitroxide radical undergoing a diffusion motion in a com-
plex ﬂuid and has been successfully applied to a variety of cases
[27–29], allowing the calculation of a theoretical ESR spectrum.
In terms of parameters, the outputs are: rotational diffusion rates
around axes deﬁned in a molecular reference frame and expressed
as the components of an R-tensor (in this paper, we used R and N
that are the components of the tensor in a spherical representation
with R being the geometric mean R ¼ RxRyRz and N the axial rota-
tional anisotropy N  Rz=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃ
RxRy
p
); order parameter S, calculated
from the coefﬁcients of a restoring potential (c20, c22) that gov-
erns the diffusion of the probe in a medium with microscopic
ordering; line broadenings that can be Gaussian (DG) or Lorentzian
(W) and take into account contributions due to inhomogeneous
broadenings. All parameters and their deﬁnitions are well de-
scribed in the seminal paper by Budil et al. [26]. The magnetic ten-
sors that describe the Zeeman (g-tensor) and hyperﬁne (A-tensor)
interactions are input parameters taken from the literature in cases
where similar structural environments to those found in this work
were described. These magnetic parameters are allowed to vary
only at the end of the simulation routines as a way of getting the
ﬁnest adjustment of the experimental spectra. In the cases where
a multi-component spectrum is being simulated the program also
gives the percentage population for each component.3. Results and discussions
EcDHODH contains four native cysteine residues that needed to
be replaced in order to achieve the speciﬁcity required for site di-
rected spin labeling experiments. Hence the ﬁrst step in our study
was to produce a pseudo-native enzyme where each cysteine was
mutated to an alanine residue. Previous studies on class2 DHODHs
have shown that protein structure and stability are not dependent
of N-terminal extension. Truncated versions of malarial DHODH
have already been used in order to kinetically characterize the en-
zyme and search for new inhibitors [30,31]. In fact, the N-terminal
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Fig. 2. Room temperature ESR spectra (solid line) along with the best ﬁt (dashed
line) from NLSL simulations of the mutants containing the probe at positions Y2 (A)
and F5 (B).
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core, where the enzymatic mechanism takes place (Fig. 1A). So
we do not expect that the exchange of one native residue for a la-
beled cysteine will dramatically affect the overall structure. Be-
sides, the pseudo-native enzyme maintained native-like activity
as evidenced from kinetic assays (see Supplementary material).
Starting from this pseudo-native form and to probe the dynamics
experienced by the N-terminal extension of EcDHODH, we selec-
tively replaced residues 2, 5, 19, and 21 for cysteines, which were
in turn used to label the protein, giving rise to four mutants: Y2R1
and F5R1 located in the beginning of the N-terminal extension, and
H19R1 and F21R1 positioned in the second helix of that region
(Fig. 1).
Shown in Fig. 2 are the ESR spectra of the Y2R1 and F5R1 EcD-
HODH mutants incorporated into DOPC/Triton X-100 mixed vesi-
cles. These spectra have been normalized to the same number of
spins so that their amplitudes provide an approximate measure-
ment of the dynamics of the spin-label side chain (more mobile
spin-labels have larger amplitudes) and, in each case, the shape
of the spectrum reﬂects the motion of the nitroxide on the nano-
second time scale. A qualitative analysis of Y2R1 and F5R1 spectra
allows us to infer that both residues experience a high degree of
freedom that is compatible with their location in the beginning
of the protein chain. Their spectra are typical of residues in loops
or in the ﬁrst turn of a helix with no major structural contacts [32].
The spectra obtained from H19R1 and F21R1 mutants in mixed
vesicles are shown in Fig. 3. These clearly show the presence of two
spectral components associated with labeled molecules either in a
strongly immobilized regime or subjected to a fast motion. The
presence of a somewhat high mobility component in these two
mutants is surprising due to the fact that they were expected to
be located right in the core of the more hydrophobic region of
the model membrane. Another interesting feature of H19R1 and
F21R1 spectra can be found by simply comparing their lineshapes
that point to different degrees of probe mobility even though the
labeled positions are just two residues apart from each other.
To further investigate and quantify the dynamic structure ob-
served for each EcDHODH mutant, we used a lineshape analysis
based on the non-linear least-squares (NLLS) simulation protocol
developed by Freed and co-workers [25,26]. In such a protocol a
calculated ESR spectrum is generated by solving the Stochastic
Liouville equation for a nitroxide moiety under a classical aniso-
tropic motion and subjected to interactions described by an ade-
quate spin Hamiltonian. In the simulations presented in this
paper we used a graphical LabView interface for the original NLSLFig. 1. Overall structure of EcDHODH (PDB ID:1F76) showing: (A) that the N-terminal ex
of a ﬂexible region; (B) residues used for labeling the protein (red circles). (For interpretat
version of this article.)program as implemented in the software available from Dr. Chris-
tian Altenbach website. The simulation procedure allows one to
determine parameters that characterize dynamics, expressed as a
rotation diffusion rate (R), and structure, in the form of an order
parameter (S).
The simulations of the spectra obtained from Y2R1 and F5R1
mutants could not be satisfactorily done with the use of only a sin-
gle component. Several attempts using just one spectral compo-tension (yellow) and the dihydrogenase domain (magenta) are connected by means
ion of the references to colour in this ﬁgure legend, the reader is referred to the web
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Fig. 3. Room temperature ESR spectra (solid line) along with the best ﬁt (dashed
line) from NLSL simulations of the mutants containing the probe at positions H19
(A) and F21 (B).
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that the peaks were in fact broader than it could be achieved even
when large broadenings were introduced in the simulation routine.
This is a clear indication that another species is present and also
demonstrates one great advantage of running NLLS simulations,
which is the identiﬁcation of spectral features that would be
‘‘invisible’’ to the naked eye. On the other hand, the ESR spectra
of H19R1 and F21R1 (Fig. 3) clearly contain two spectral compo-
nents and were simulated accordingly. However, the use of more
than one component in NLLS simulations always implies the exer-
cise of caution when it comes to deﬁning the number of parame-
ters being used in the calculations. Our strategy to avoid pitfallsTable 1
Parameters obtained from NLSL simulations of the EcDHODH mutants.
Y2R1 F5R1
1 2 1 2
Axx 6.2 6.2 6.2 6.2
Ayy 5.9 5.9 5.9 5.9
Azz 37.8 35.2 35.5 37.5
gxx 2.0076 2.0076 2.0076 2.0076
gyy 2.0050 2.0050 2.0050 2.0050
gzz 2.0023 2.0023 2.0023 2.0023
R 0.85  108 0.55  109 0.36  109 0.35  109
N 0.31 0.47 1.19 0.42
S 0.33 – 0.01 –
% 76 23 59 41
Hyperﬁne tensor components are in Gauss and R values are in s1.
Estimated errors: R (5%), Azz (5%), N (10%).was to keep the number of parameters to the minimum needed
to produce a reasonable agreement between experimental and the-
oretical spectra. That required a careful simulation routine where
we started calculations using several combinations of dynamics
(R components), ordering (c20) and/or broadening mechanisms
(Gaussian or Lorentzian). After restarting simulations from several
different sets of seed values and taking all precautions described,
we determined the set of parameters in Table 1.
From the data for the Y2R1 mutant (Table 1), we can infer that
the beginning of the N-terminal region in the presence of the mod-
el membrane coexists in two different conformations: one sub-
jected to a more restricted motion (dotted spectrum in Fig. 2A)
and a component that shows the fastest motion observed in this
region with an R value of 0.55  109 s1 (dash-dotted spectrum
in Fig. 2A). These two states are not equally populated with a pref-
erence for the more immobilized species (76%). As for ordering, the
Y2R1 parameters show that the fast-motion component does not
feel any sort of restoring potential (S = 0), while the more immobi-
lized species has an order parameter of 0.33, which indicates an
intermediate ordering.
The simulation of the F5R1 spectrum showed the coexistence of
two spin probe populations. Unlike Y2R1, the two species now
present similar diffusion rates (R of 0.36  109 s1), but with differ-
ent degrees of motion asymmetry expressed in the N parameter,
which basically represents the ratio in the diffusion rates along
the directions of a molecular reference frame constituted by the
direction of the NO bond (x-axis), the normal axis to the aromatic
ring containing the nitroxide moiety (z-axis) and a direction that
makes an orthogonal system with the x and z. An either very low
or null restoring potential was needed for the simulations of the
two components. Hence, we can infer that the components de-
tected at position 5 of the polypeptide chain in the presence of
the model membrane have very little orienting preferences and
both undergo a fast motion but with different degrees of
anisotropy.
In the case of the H19R1 spectrum, although it clearly contains
two spectral components (Fig. 3A), the parameters in Table 1 indi-
cate that one of those species is low populated (13%), characterized
by a very fast motion with no ordering and a very high average
hyperﬁne splitting [A0 = (Ax + Ay + Az )/3 = 16.6 G]. A0 values are
used as a measure of the polarity around the spin label moiety with
high values (above ca. 16 G) representing polar environments. This
information suggests that such component must be due to a spin
label population that did not react with the cysteine residues and
could not be completely removed during the enzyme puriﬁcation.
The second component, on the other hand, is characterized by slow
motion (R = 0.42  107 s1) and very high ordering (S = 0.91) of the
spin probe at position 19, indicating that this part of the polypep-H19R1 F21R1
1 2 1 2
6.9 5.6 5.5 6.2
5.0 5.0 5.5 5.9
35.4 39.2 38.8 37.8
2.0078 2.0078 2.0081 2.0067
2.0058 2.0055 2.0046 2.0055
2.0019 2.0023 2.0015 2.0029
0.42  107 0.72  109 0.42  108 0.95  109
0.36 1.00 0.69 1.15
0.91 – 0.29 –
87 13 83 17
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the presence of the model membrane system.
Finally, the spectrum of the F21R1 mutant also shows two spec-
tral components with one of them attributable to free spin label
(component 2 in Table 1). The other component is associated with
spin probes in a slow motion regime but, unlike the H19R1 case,
with relatively low ordering (S = 0.29). Hence, at this position,
the probe undergoes an intermediate rotational diffusion
(R = 0.42  108 s1) with larger amplitude than it was observed
for H19R1. The nitroxide experiences several different orientations
in a somewhat longer time scale. This situation is probably the re-
sult of a less tightly packed arrangement of the helix at position 21
than 19.
Taking together the information discussed above we can say
that the N-terminal region of EcDHODH in the presence of a model
membrane system is characterized by:
(1) Coexistence of two conformations in the ﬁrst helix of the
region as inferred from the ESR spectra and simulations
obtained for the Y2R1 and F5R1 mutants (Fig. 2 and Table
1). This helix is more ﬂexible (higher rotational diffusion
rates) and with larger amplitude motions (lower ordering
parameters) than the other helix that composes the N-termi-
nal domain.
(2) The second helix of the N-terminal domain is in a more rigid
conformation. However, the dynamics and ordering experi-
enced by residues 19 and 21 are distinct and point to a very
well-deﬁned orientation of the side chain of residue 19 as
compared to residue 21. This is in agreement with what
would be expected from the protein crystal structure [15],
where it is seen that residue 19 points inwards (facing the
protein’s interior) while residue 21 assumes an orientation
with its side chain in a less packed structural environment.
The co-existence of conformations in helix 1 and the low order-
ing experienced by the probe at position 21 suggest that the N-ter-
minal extension is ﬂexible enough to undergo an open/close
structural transition with helix 1 being the region with larger
amplitude and faster motions, whereas helix 2 would be more
tightly packed against the protein structure. The swapping ob-
served for residues 2 and 5 between a more mobile and a more
immobile conformation is compatible with an open/close struc-
tural transition where the more immobile component is the one
adopted in the closed state and is likely to bring the residue side
chain in closer proximity with the protein inside, whereas the
more ﬂexible species is associated with the helix experiencing a
much less restricted motion due to its location farther away from
the protein structural elements and in contact with the less packed
mixed micelle interior, which would then allow for the higher
dynamics observed in the ESR spectra of Y2R1 and F5R1. This ﬂex-
ibility guarantees that the N-terminal domain would work as a sort
of lid that controls the access to the b-barrel domain, where the en-
zyme’s active site is located. We believe that this would be the
mechanism used by the protein to ﬁsh out the quinones, which
act as electron acceptors and that are dispersed in the membrane,
and then conduct the enzymatic catalysis. Our results shed light on
the molecular mechanism used by EcDHODH to convert dihydro-
orotate to orotate and, to the best of our knowledge, are the ﬁrst
experimental evidence showing that the N-terminal region inter-
acts with membranes and, furthermore, it exerts a major role dur-
ing catalysis.
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